GHCM
AGN

Glen Harbor Capital Management’s Allergan plc AGN Stock Holding History

Glen Harbor Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$2.45M Sell
14,552
-54,162
-79% -$8.82M 0.05% 296
2019
Q2 		$11.5M Sell
68,714
-25,364
-27% -$3.51M 0.24% 88
2019
Q1 		$13.8M Buy
94,078
+35,292
+60% +$5.12M 0.3% 79
2018
Q4 		$7.86M Buy
58,786
+32,640
+125% +$5.35M 0.19% 110
2018
Q3 		$4.98M Sell
26,146
-6,018
-19% -$1.11M 0.1% 200
2018
Q2 		$5.36M Buy
32,164
+8,194
+34% +$1.32M 0.12% 177
2018
Q1 		$4.03M Buy
23,970
+12,886
+116% +$2.16M 0.09% 203
2017
Q4 		$1.81M Buy
11,084
+2,176
+24% +$390K 0.04% 317
2017
Q3 		$1.83M Buy
8,908
+34
+0.4% +$7.91K 0.04% 305
2017
Q2 		$2.16M Sell
8,874
-57,154
-87% -$13.4M 0.05% 277
2017
Q1 		$15.8M Sell
66,028
-2,992
-4% -$697K 0.39% 58
2016
Q4 		$14.5M Buy
+69,020
New +$14.3M 0.39% 55

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Glen Harbor Capital Management's AGN Position: Q3 2019 in Review

Glen Harbor Capital Management reduced its Allergan plc (AGN) stake by 79% in Q3 2019, selling an estimated $8.82M and leaving 14,552 shares worth $2.45M. The position accounts for 0.05% of the portfolio, ranked #296.

Glen Harbor Capital Management first reported a position in AGN in Q4 2016 and has held it in 12 quarters since. The position peaked at $15.8M in Q1 2017. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • Glen Harbor Capital Management held 14,552 shares of Allergan plc worth $2.45M as of Q3 2019.
  • Glen Harbor Capital Management sold 54,162 Allergan plc shares in Q3 2019, an estimated $8.82M.
  • Allergan plc made up 0.05% of Glen Harbor Capital Management's portfolio in Q3 2019, its #296 holding.
  • Glen Harbor Capital Management first reported a position in Allergan plc in Q4 2016 and has held it in 12 quarters since.
  • Glen Harbor Capital Management's Allergan plc position peaked at $15.8M in Q1 2017.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Glen Harbor Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.